GM-CSF Receptors on Light Density JMML and CMML Peripheral Blood and Normal Marrow Cells
| Patient . | Disease . | High-Affinity Receptors/Cell . | kd × 10−11 . |
|---|---|---|---|
| AJ | JMML | 141 | 1.2 |
| NL | JMML | ND | ND |
| HA | JMML | ND | ND |
| CF | JMML | 164 | 0.6 |
| PR | JMML | 119 | 0.6 |
| MS | JMML | 310 | 0.6 |
| CB | JMML | 539 | 2 |
| G | CMML | 636 | 2 |
| CL | CMML | 344 | 1.2 |
| RS | CMML | 624 | 1.1 |
| WS | CMML | 188 | 0.8 |
| AR | CMML | 384 | 1.4 |
| JT | CMML | 657 | 2 |
| CT | CMML | 1512 | 1.3 |
| LS | CMML | 268 | 0.6 |
| RB | CMML | 1720 | 1.3 |
| WB | CMML | 1100 | 2.9 |
| FB | CMML | 490 | 2.9 |
| GN | CMML | 310 | 0.5 |
| GW | CMML | 240 | 0.3 |
| RM | CMML | 990 | 2 |
| EB | CMML | 350 | 2.9 |
| KP | CMML | 170 | 2 |
| SB | CMML | 420 | 1 |
| PP | CMML | 410 | 2 |
| DJ | CMML | 330 | 1 |
| ED | CMML | 890 | 2.6 |
| LP | CMML | 340 | 1.5 |
| CAD253-150 | Normal | 525 | 0.4 |
| CAD3-150 | Normal | 159 | 1 |
| U11802 | Normal | 420 | 0.6 |
| U11811 | Normal | 580 | 1 |
| U11454 | Normal | 16 | 0.3 |
| Patient . | Disease . | High-Affinity Receptors/Cell . | kd × 10−11 . |
|---|---|---|---|
| AJ | JMML | 141 | 1.2 |
| NL | JMML | ND | ND |
| HA | JMML | ND | ND |
| CF | JMML | 164 | 0.6 |
| PR | JMML | 119 | 0.6 |
| MS | JMML | 310 | 0.6 |
| CB | JMML | 539 | 2 |
| G | CMML | 636 | 2 |
| CL | CMML | 344 | 1.2 |
| RS | CMML | 624 | 1.1 |
| WS | CMML | 188 | 0.8 |
| AR | CMML | 384 | 1.4 |
| JT | CMML | 657 | 2 |
| CT | CMML | 1512 | 1.3 |
| LS | CMML | 268 | 0.6 |
| RB | CMML | 1720 | 1.3 |
| WB | CMML | 1100 | 2.9 |
| FB | CMML | 490 | 2.9 |
| GN | CMML | 310 | 0.5 |
| GW | CMML | 240 | 0.3 |
| RM | CMML | 990 | 2 |
| EB | CMML | 350 | 2.9 |
| KP | CMML | 170 | 2 |
| SB | CMML | 420 | 1 |
| PP | CMML | 410 | 2 |
| DJ | CMML | 330 | 1 |
| ED | CMML | 890 | 2.6 |
| LP | CMML | 340 | 1.5 |
| CAD253-150 | Normal | 525 | 0.4 |
| CAD3-150 | Normal | 159 | 1 |
| U11802 | Normal | 420 | 0.6 |
| U11811 | Normal | 580 | 1 |
| U11454 | Normal | 16 | 0.3 |
Determined by Scatchard analysis between 0.6 pmol/L and 26 pmol/L125I-GM-CSF as described in the text. There were insufficient cells from patients NL, HA, CAD24D for receptor analyses.
CAD25 and CAD were CD34+ cells.